臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 371-420 / 1137 (共23頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-04-23T05:56:28Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Chih-Hsin Yang;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2021-03-19T06:58:09Z	Echogenic floating spherules as a sonographic sign of cystic teratoma of mediastinum: Correlation with CT and pathologic findings	Shih J.-Y.; Wang H.-C.; Chang Y.-L.; YEUN-CHUNG CHANG; Lee Y.-C.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:55Z	Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response	Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; YEUN-CHUNG CHANG; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:52Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; YEUN-CHUNG CHANG; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:51Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:47Z	Epidermal growth factor receptor mutations in small cell lung cancer: A brief report	Shiao T.-H.;Chang Y.-L.;Yu C.-J.;Yeun-Chung Chang;Hsu Y.-C.;Chang S.-H.;Shih J.-Y.;Yang P.-C.; Shiao T.-H.; Chang Y.-L.; Yu C.-J.; YEUN-CHUNG CHANG; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:46Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y.;Yu C.-J.;Yeun-Chung Chang;Yang C.-H.;Shih J.-Y.;Yang P.-C.; Wu J.-Y.; Yu C.-J.; YEUN-CHUNG CHANG; Yang C.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:46Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.;Wu S.-G.;Yang C.-H.;Chang Y.-L.;Yeun-Chung Chang;Hsu Y.-C.;Shih J.-Y.;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; YEUN-CHUNG CHANG; Hsu Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:44Z	Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation	Lu C.-H.; Hsiao C.-H.; YEUN-CHUNG CHANG; Lee J.-M.; Shih J.-Y.; Wu L.-A.; Yu C.-J.; Liu H.-M.; Shih T.T.-F.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:43Z	Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment	Chung K.-P.; Huang Y.-T.; Chang Y.-L.; Yu C.-J.; Yang C.-H.; YEUN-CHUNG CHANG; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:39Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Wu S.-G.;Hu F.-C.;Chang Y.-L.;Lee Y.-C.;Yu C.-J.;Yeun-Chung Chang;Wu J.-Y.;Shih J.-Y.;Yang P.-C.; Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; YEUN-CHUNG CHANG; Wu J.-Y.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:35Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	Lee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; YEUN-CHUNG CHANG; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H.
臺大學術典藏	2021-03-19T06:57:27Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Liao B.-C.; Bai Y.-Y.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; YEUN-CHUNG CHANG; Yu C.-J.; Yang J.
臺大學術典藏	2021-03-19T06:57:20Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Liao B.-C.;Bai Y.-Y.;Lee J.-H.;Lin C.-C.;Lin S.-Y.;Lee Y.-F.;Ho C.-C.;Shih J.-Y.;Yeun-Chung Chang;Yu C.-J.;Chih-Hsin Yang J.;Yang P.-C.; Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; YEUN-CHUNG CHANG; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:17Z	Detecting small pulmonary nodules with spiral ultrashort echo time sequences in 1.5?T MRI	Huang Y.-S.;Niisato E.;Su M.-Y.M.;Benkert T.;Hsu H.-H.;Shih J.-Y.;Chen J.-S.;Yeun-Chung Chang; Huang Y.-S.; Niisato E.; Su M.-Y.M.; Benkert T.; Hsu H.-H.; Shih J.-Y.; Chen J.-S.; YEUN-CHUNG CHANG
臺大學術典藏	2021-03-18T08:54:15Z	In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry	Chen K.-C.; Yin W.-H.; Wu C.-C.; Chan S.-H.; YEN-WEN WU; Wang K.Y.; Chang K.-C.; Hwang J.-J.; Voon W.-C.; Hsieh I.-C.; Chong J.-T.; Lin W.-S.; Hsu C.-N.; Ueng K.-C.; Hsia C.-P.; Liu J.-C.; Yeh J.-S.; Mar G.-Y.; Shih J.-Y.; Kuo J.-Y.; Tsao H.-M.; Tseng W.-K.; Yang C.-H.; Chang C.-C.; Chiang C.-E.; Lei M.-H.; Lin J.-F.; Shyu K.-G.
臺大學術典藏	2021-03-18T02:03:20Z	Sialyl Lewis antigens: Association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer	Yu C.-J.;Shih J.-Y.;Lee Y.-C.;Chia-Tung Shun;Yuan A.;Yang P.-C.; Yu C.-J.; Shih J.-Y.; Lee Y.-C.; CHIA-TUNG SHUN; Yuan A.; Yang P.-C.
臺大學術典藏	2021-03-18T02:03:01Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; CHIA-TUNG SHUN; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.
臺大學術典藏	2021-03-13T03:29:30Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	YEN-FU CHEN; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2021-03-13T03:29:28Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	YEN-FU CHEN; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2021-03-13T03:29:28Z	Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit	Yen-Fu Chen;Lin J.-W.;Ho C.-C.;Yang C.-Y.;Chang C.-H.;Huang T.-M.;Chen C.-Y.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; YEN-FU CHEN; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-13T03:29:27Z	Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation	Keng L.-T.;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Yen-Fu Chen;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; YEN-FU CHEN; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-13T03:29:25Z	Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study	Chen Y.-H.;Yen-Fu Chen;Chen C.-Y.;Shih J.-Y.;Yu C.-J.; Chen Y.-H.; YEN-FU CHEN; Chen C.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-12T02:29:07Z	Nontuberculous mycobacteria isolates: Clinical significance and disease spectrum	Shih J.-Y.;Hsueh P.-R.;Li-Na Lee;Wang H.-C.;Yang P.-C.;Kuo S.-H.;Luh K.-T.; Shih J.-Y.; Hsueh P.-R.; LI-NA LEE; Wang H.-C.; Yang P.-C.; Kuo S.-H.; Luh K.-T.
臺大學術典藏	2021-03-12T02:29:07Z	Sonographic imaging of the trachea	Shih J.-Y.;Li-Na Lee;Wu H.-D.;Yu C.-J.;Wang H.-C.;Chang Y.-L.;Yang P.-C.; Shih J.-Y.; LI-NA LEE; Wu H.-D.; Yu C.-J.; Wang H.-C.; Chang Y.-L.; Yang P.-C.
臺大學術典藏	2021-03-12T02:29:06Z	Tracheal botryomycosis in a patient with tracheopathia osteochondroplastica	Shih J.-Y.;Hsueh P.-R.;Chang Y.-L.;Li-Na Lee;Chen Y.-C.;Chen M.-F.;Luh K.-T.; Shih J.-Y.; Hsueh P.-R.; Chang Y.-L.; LI-NA LEE; Chen Y.-C.; Chen M.-F.; Luh K.-T.
臺大學術典藏	2021-03-12T02:29:00Z	Tuberculous myositis: A rare but existing clinical entity	Wang J.Y.;Li-Na Lee;Hsueh P.R.;Shih J.Y.;Chang Y.L.;Yang P.C.;Luh K.T.; Wang J.Y.; LI-NA LEE; Hsueh P.R.; Shih J.Y.; Chang Y.L.; Yang P.C.; Luh K.T.
臺大學術典藏	2021-03-12T02:28:41Z	Coinfection with Mycobacterium tuberculosis and pandemic H1N1 influenza A virus in a patient with lung cancer	Tan C.-K.;Kao C.-L.;Shih J.-Y.;Li-Na Lee;Hung C.-C.;Lai C.-C.;Huang Y.-T.;Hsueh P.-R.; Tan C.-K.; Kao C.-L.; Shih J.-Y.; LI-NA LEE; Hung C.-C.; Lai C.-C.; Huang Y.-T.; Hsueh P.-R.
臺大學術典藏	2021-03-12T00:50:59Z	Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy	Tsai T.-H.;Yang C.-Y.;Ho C.-C.;Liao W.-Y.;I-Shiow Jan;Chen K.-Y.;Wang J.-Y.;Ruan S.-Y.;Yu C.-J.;Yang J.C.H.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; I-SHIOW JAN; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2021-03-12T00:50:59Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.;Yu C.-J.;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;I-Shiow Jan;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; I-SHIOW JAN; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2021-03-12T00:50:57Z	BMVC test, an improved fluorescence assay for detection of malignant pleural effusions	Lin I.-T.; Tsai Y.-L.; Kang C.-C.; Huang W.-C.; Wang C.-L.; Lin M.-Y.; Lou P.-J.; Shih J.-Y.; Wang H.-C.; Wu H.-D.; Tsai T.-H.; I-SHIOW JAN; Chang T.-C.
臺大學術典藏	2021-03-11T12:03:49Z	The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer	Yu K.-L.;Tsai T.-H.;Ho C.-C.;Liao W.-Y.;Ching-Kai Lin;Hsu C.-L.;Shih J.-Y.; Yu K.-L.; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; CHING-KAI LIN; Hsu C.-L.; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:21Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:15Z	Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort	SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T08:34:15Z	Effect of β-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Lee C.-H.; JEN-CHANG KO; LIH-YU CHANG; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T08:29:35Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:29:34Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:29:32Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2021-03-11T08:29:30Z	Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs	Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T08:29:29Z	Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort	Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T07:58:31Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T07:58:28Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T07:58:27Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2021-03-11T07:58:25Z	Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs	Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T07:58:24Z	Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort	Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-08T06:51:51Z	Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression	Lin C.-C.; Huang Y.-K.; Cho C.-F.; Lin Y.-S.; Lo C.-C.; Kuo T.-T.; Tseng G.-C.; Cheng W.-C.; Chang W.-C.; Hsiao T.-H.; Liang-Chuan Lai; Shih J.-Y.; Liu Y.-H.; Clifford Chao K.S.; Hsu J.L.; Lee P.-C.; Sun X.; Hung M.-C.; Sher Y.-P.
臺大學術典藏	2021-02-23T08:26:39Z	Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response	Gow C.-H.;Chien C.-R.;Chang Y.-L.;Chiu Y.-H.;Sung-Hsin Kuo;Shih J.-Y.;Chang Y.-C.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; SUNG-HSIN KUO; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2021-02-23T08:26:37Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; SUNG-HSIN KUO; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.

顯示項目 371-420 / 1137 (共23頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52800591 線上人數 : 631 教育部委託研究計畫計畫執行:國立臺灣大學圖書館